Genetics News and Research

Latest Genetics News and Research

Plexin D1 gene determines body fat distribution in humans

Scientists have known for some time that people who carry a lot of weight around their bellies are more likely to develop diabetes and heart disease than those who have bigger hips and thighs.

24 Mar 2015

Men who exercise more have better erectile and sexual function

Men who exercise more have better erectile and sexual function, regardless of race, according to a recent study published in the Journal of Sexual Medicine.

24 Mar 2015

Genetic flaws in bowel cancer may trigger immune response at site of tumours

Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today (Monday) in the journal Oncoimmunology.

23 Mar 2015

How our DNA may prevent bowel cancer

The link between taking aspirin, and similar medications called non-steroidal anti-inflammatory drugs (or NSAIDS), and bowel (colorectal) cancer prevention is well established.

23 Mar 2015

Existing drugs could help prevent deadly familial stomach and lobular breast cancers

Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.

23 Mar 2015

Pathogen may cause high levels of virulence in closely-related hosts

When viruses such as influenza and Ebola jump from one species to another, their ability to cause harm can change dramatically, but research from the University of Cambridge shows that it may be possible to predict the virus's virulence by looking at how deadly it is in closely-related species.

23 Mar 2015

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Amgen today announced that an application seeking marketing approval of Repatha (evolocumab) for the treatment of high cholesterol has been submitted for review to the Ministry of Health, Labour and Welfare in Japan.

21 Mar 2015

Targeted drug doubles progression free survival in Hodgkin lymphoma

A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).

19 Mar 2015

β-amyloid cleared of blame for early memory decline

A “seminal” imaging study suggests that worsening memory in adults is not necessarily an indicator of β-amyloid deposition.

19 Mar 2015

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.

19 Mar 2015

UVA researcher identifies potential therapeutic target for myotonic muscular dystrophy

A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could modify progression of muscle damage and muscle dysfunction associated with the disease - issues that cause patients significant disability and deterioration in quality of life.

19 Mar 2015

Genetic markers may help decide who benefits from aspirin, NSAIDs in lowering risk of colorectal cancer

An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.

18 Mar 2015

UT Southwestern neuroscientists identify key brain cells that control circadian rhythms

UT Southwestern Medical Center neuroscientists have identified key cells within the brain that are critical for determining circadian rhythms, the 24-hour processes that control sleep and wake cycles, as well as other important body functions such as hormone production, metabolism, and blood pressure.

18 Mar 2015

New research identifies promising drug therapy target for breast cancer

The genome of a cell is under constant attack, suffering DNA damage that requires an army of repair mechanisms to keep the cell healthy and alive. Understanding the behavior of the enzymes defending these assaults helps determine how - and where - cancer gets its foothold and flourishes.

18 Mar 2015

CMU scientists trace the brain processes that occur while learning new technical concepts

For the first time, Carnegie Mellon University scientists have traced the brain processes that occur during the learning of technical concepts. Published in NeuroImage, the findings reveal how new technical knowledge is built up in the brain during the course of different learning stages.

18 Mar 2015

GW, Children's National researchers awarded $6.2 million grant to solve pediatric dysphagia

An interdisciplinary group of researchers from the George Washington University School of Medicine and Health Sciences and Children's National Health System has been awarded a program project grant (PPG) for $6.2 million from The Eunice Kennedy Shriver National Institute of Child Health and Human Development to solve pediatric dysphagia -- a chronic difficulty with feeding and swallowing in children.

17 Mar 2015

Genetics News and Research

Latest Genetics News and Research

Plexin D1 gene determines body fat distribution in humans

Men who exercise more have better erectile and sexual function

Genetic flaws in bowel cancer may trigger immune response at site of tumours

How our DNA may prevent bowel cancer

Existing drugs could help prevent deadly familial stomach and lobular breast cancers

Pathogen may cause high levels of virulence in closely-related hosts

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Targeted drug doubles progression free survival in Hodgkin lymphoma

β-amyloid cleared of blame for early memory decline

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

UVA researcher identifies potential therapeutic target for myotonic muscular dystrophy

Genetic markers may help decide who benefits from aspirin, NSAIDs in lowering risk of colorectal cancer

UT Southwestern neuroscientists identify key brain cells that control circadian rhythms

New research identifies promising drug therapy target for breast cancer

CMU scientists trace the brain processes that occur while learning new technical concepts

GW, Children's National researchers awarded $6.2 million grant to solve pediatric dysphagia

Researchers identify new gene variants that could contribute to sporadic motor neurone disease

Ruthigen, Pulmatrix sign definitive merger agreement

Common herpes drug Valacyclovir decreases HIV-1 levels

MGH study suggests that bariatric surgery can reduce risk of asthma attacks

eBook: Using iPSCs models for human disease research and drug discovery eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh